Abstract
The prevalence of hypoxic respiratory failure in patients with COVID-19 has been reported in 19%. Recent reports from China showed that 4–13% of COVID-19 patients in these studies received noninvasive positive pressure ventilation (NIPPV), and that 2.3–12% required invasive mechanical ventilation. Although the true incidence of hypoxic respiratory failure in patients with COVID-19 is not clear, it appears that about 14% will develop severe disease requiring oxygen therapy, and 5% will require ICU admission and mechanical ventilation [1]. Some studies have shown that avoiding invasive mechanical ventilation (IMV) significantly decreases the risk of death [2, 3]. This is why choosing an optimal oxygen therapy device is very important for reducing the rates of IMV and mortality while also ensuring patients’ safety and comfort [4]. The CDC reported an overall case-fatality rate (CFR) of 2.3%, with a CFR of 14.8% in patients aged 80 years or older [1]. We must consider oxygen therapy if [4, 5]:
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alhazzani W, Moller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020;48:e440.
Azevedo LC, Caruso P, Silva UV, et al. Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. Chest. 2014;146(2):257–66.
Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a Groupe de Recherche Respiratoire en reanimation Onco-Hématologique study. J Clin Oncol. 2013;31(22):2810–8.
Zhu Y, Yin H, Zhang R, et al. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute respiratory failure: a systematic review and meta-analysis of randomized controlled trials. BMC Pulm Med. 2017;17:201.
Cinesi C, Peñuelas O, Luján MI, et al. Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2. Med Int. 2020; https://doi.org/10.1016/j.medin.2020.03.005.
Brill S, Wedzicha J. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Int J COPD. 2014;9:1241–52.
Masclans JR, Pérez-Terán P, Roca O. The role of high-flow oxygen therapy in acute respiratory failure. Med Int. 2015;39(8):505–15.
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–96.
Walter J, Corbridge T, Singer B. Invasive mechanical ventilation. South Med J. 2018 December;111(12):746–53.
Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2016;315:2435–41.
Scala R. Challenges on non-invasive ventilation to treat acute respiratory failure in the elderly. BMC Pulm Med. 2016;16:150.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Úbeda, A., Fernández, I. (2020). Escalation Therapy for ARFin Elderly Patient. In: Vargas, N., Esquinas, A.M. (eds) Covid-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients. Springer, Cham. https://doi.org/10.1007/978-3-030-55621-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-55621-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-55620-4
Online ISBN: 978-3-030-55621-1
eBook Packages: MedicineMedicine (R0)